UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European journal of heart failure, ISSN 1388-9842, 01/2017, Volume 19, Issue 1, pp. 9 - 42
cancer therapy | cardiotoxicity | ischaemia | European Society of Cardiology | arrhythmias | myocardial dysfunction | cardio-oncology | early detection | surveillance | chemotherapy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Congresses as Topic | Societies, Medical | Antineoplastic Agents - adverse effects | Europe | Humans | Antineoplastic Agents - therapeutic use | Cardiotoxicity | Cardiology | Heart Diseases - chemically induced | Neoplasms - drug therapy | Practice Guidelines as Topic | Index Medicus | Life Sciences | Human health and pathology | Surgery | Cardiology and cardiovascular system
Journal Article
The Lancet (British edition), ISSN 0140-6736, 04/2019, Volume 393, Issue 10179, pp. 1440 - 1452
Journal Article
The Lancet (British edition), ISSN 0140-6736, 04/2019, Volume 393, Issue 10179, pp. 1440 - 1452
Female | Antineoplastic Agents - administration & dosage | Drug Administration Schedule | Breast Neoplasms - pathology | Breast Neoplasms - drug therapy | Humans | Prevention | Anthracyclines | Oncology, Experimental | Analysis | Mortality | Estrogen | Adjuvant treatment | Rankings | Breast cancer | Research | Cancer | Drugs | Intervals | Schedules | Clinical trials | Cytotoxicity | Oncology | Taxane | Dosage | Cancer therapies | Evidence-based medicine | Randomization | Risk assessment | Information sharing | Sequential scheduling | Colony-stimulating factor | Drug dosages | Bibliographic data bases | Medical research | Health risks | Histology | Patients | Meta-analysis | Chemotherapy | Anthracycline | Womens health | Collaboration | Health risk assessment | Tumors | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 19, pp. 1836 - 1846
no | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Prognosis | Drug Administration Schedule | Receptors, Estrogen | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Risk | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Neoplasm Metastasis | Neoplasm Grading | Estrogen Antagonists - therapeutic use | Breast Neoplasms - pathology | Adult | Breast Neoplasms - mortality | Female | Aged | Chemotherapy, Adjuvant | Care and treatment | Usage | Relapse | Hormone therapy | Patient outcomes | Breast cancer | Risk factors | Cancer | Medical research | Lymphatic system | Clinical trials | Estrogen receptors | Endocrine therapy | Patients | ErbB-2 protein | Clinical outcomes | Studies | Epidermal growth factor | Womens health | Progesterone | Age | Trastuzumab | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 383, Issue 9935, pp. 2127 - 2135
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | General aspects | Biological and medical sciences | Surgery of the genital tract and mammary gland | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Tumors | Lymph Node Excision | Breast Neoplasms - surgery | Breast Neoplasms - radiotherapy | Humans | Neoplasm Recurrence, Local | Axilla | Mastectomy | Breast Neoplasms - mortality | Female | Lymphatic Metastasis | Randomized Controlled Trials as Topic | Usage | Care and treatment | Breast cancer | Research | Radiotherapy | Patient outcomes | Radiation therapy | Womens health | Mortality | Clinical outcomes | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article